Nebenwirkungen · Clopidogrel TAD
Clopidogrel TAD 75 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10–11
HOS-212144 · Präparat HOS-154832
10 System Organ Common Uncommon Rare Very rare, not Class known* Blood and the Thrombocytopenia, Neutropenia, Thrombotic lymphatic leucopenia, including severe thrombocytopenic system disorders eosinophilia neutropenia purpura (TTP) (see section 4.4), aplastic anaemia, pancytopenia, agranulocytosis, severe thrombocytopenia, acquired haemophilia A, granulocytopenia, anaemia Cardiac Kounis syndrome disorders (vasospastic allergic angina / allergic myocardial infarction) in the context of a hypersensitivity reaction due to clopidogrel* Immune system Serum sickness, disorders anaphylactoid reactions cross-reactive drug hypersensitivity among thienopyridines (such as ticlopidine, prasugrel) (see section 4.4)*, insulin autoimmune syndrome, which can lead to severe hypoglycemia, particularly in patients with HLA DRA4 subtype (more frequent in the Japanese population)* Psychiatric Hallucinations, disorders confusion Nervous system Intracranial Taste disturbances, disorders bleeding (some ageusia cases were reported with fatal outcome), headache, paraesthesia, dizziness Eye disorders Eye bleeding (conjunctival, ocular, retinal)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-13T14:13:00Z · SHA-256 92374ef557d036eb7238428b43050aa768aa319968c19ef57a4d1f13dfef0986 · Passage 81f38b919d20cce90705189ced4d0e6d1255ec8d9035d6f6ebc541ab9ac26664 · Zeichen 3326–7538 im Abschnitt